medigraphic.com
SPANISH

Acta Pediátrica de México

Órgano Oficial del Instituto Nacional de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 3

<< Back Next >>

Acta Pediatr Mex 2018; 39 (3)

Atypical hemolytic uremic syndrome. Case report and review of the literature

Jiménez-García R, Rebolledo-Zamora A, Vázquez-Perdomo MRM, Bojórquez-Ochoa A, Corcuera-Delgado CT
Full text How to cite this article

Language: Spanish
References: 0
Page: 250-255
PDF size: 709.25 Kb.


Key words:

atypical hemolytic uremic syndrome, thrombotic microangiopathy, eculizumab.

ABSTRACT

Introduction: The hemolytic uremic syndrome in its atypical variety is a rare thrombotic microangiopathy, with high morbidity and mortality if a timely diagnosis is not available to allow an adequate specific treatment.
Clinic case: Patient with a confirmed diagnosis of atypical hemolytic uremic syndrome treated with eculizumab with total remission and satisfactory clinical evolution. Diagnostic suspicion is important for early and specific treatment and favorable prognosis.
Conclusion: The case reported here is illustrative of the clinical presentation of the atypical haemolytic uraemic syndrome. Its evolution was torpid, despite the treatment with plasma infusion and plasmapheresis and its total remission with eculizumab. In Mexico, few cases have been confirmed, only in some cases has the specific treatment been administered.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Pediatr Mex. 2018;39